Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

United Therapeutics Corp

Launch the Tyvaso label expansion for PH-ILD

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
24 Feb 2021
Due
30 Apr 2021
Delivered
April 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“In April 2021, we plan to launch a label expansion for Tyvaso, to include an indication for PH-ILD, assuming FDA approval.”

What we found

Evidence strength A What the grades mean

A 2021-05-05 8-K states the Tyvaso PH-ILD label expansion launched in April 2021, after FDA approval on March 31, 2021, meeting the April deadline.

  • A
    United Therapeutics Corp 10-Q filed 2021-05-05 Regulatory filing · published 5 May 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “Phase 3 INCREASE study successful; sNDA approved March 31, 2021” ✓ confirmed on the page
  • A
    United Therapeutics Corp 8-K filed 2021-05-05 Regulatory filing · published 5 May 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “in April 2021, we launched a label expansion for Tyvaso to include an indication for PH-ILD following FDA approval on March 31, 2021.” ✓ confirmed on the page

Checked 26 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Commercial launch
Indicative materiality
Medium rules
Action
Launch
Deliverable
Tyvaso label expansion for PH-ILD
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: assuming FDA approval
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you United Therapeutics Corp? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-UTHR-024286 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.